Welsis Corp. (WLSS) Financial Statements (2025 and earlier)
Company Profile
Business Address |
701 E CATHEDRAL RD PHILADELPHIA, PA 19128 |
State of Incorp. | WY |
Fiscal Year End | September 30 |
Industry (SIC) | 80 - Health Services (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
12/31/2024 Q1 | 9/30/2024 Q4 | 6/30/2024 Q3 | 3/31/2024 Q2 | 12/31/2023 Q1 | 9/30/2023 Q4 | 6/30/2023 Q3 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Prepaid expense | |||||||||
Other undisclosed current assets | 1 | 10 | 5 | ||||||
Total current assets: | 1 | 10 | 5 | ||||||
Noncurrent Assets | |||||||||
Intangible assets, net (including goodwill) | (15) | 17 | 19 | 21 | 23 | 25 | |||
Goodwill | (15) | ||||||||
Intangible assets, net (excluding goodwill) | 17 | 19 | 21 | 23 | 25 | ||||
Other undisclosed noncurrent assets | |||||||||
Total noncurrent assets: | (15) | 17 | 19 | 21 | 23 | 25 | |||
TOTAL ASSETS: | (15) | 17 | 19 | 23 | 33 | 31 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 17 | 10 | 7 | 87 | 91 | 81 | |||
Accounts payable | 77 | 76 | 74 | ||||||
Accrued liabilities | 15 | 12 | 10 | 9 | 16 | 7 | |||
Other undisclosed accounts payable and accrued liabilities | 2 | (2) | (3) | ||||||
Debt | 40 | ||||||||
Other undisclosed current liabilities | 15 | 12 | 10 | 27 | 20 | 27 | |||
Total current liabilities: | 72 | 22 | 18 | 114 | 111 | 108 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 18 | 40 | 40 | 40 | 40 | 40 | |||
Long-term debt, excluding current maturities | 18 | 40 | 40 | 40 | 40 | 40 | |||
Other undisclosed noncurrent liabilities | 11 | ||||||||
Total noncurrent liabilities: | 18 | 51 | 40 | 40 | 40 | 40 | |||
Total liabilities: | 90 | 73 | 58 | 154 | 151 | 148 | |||
Equity | |||||||||
Equity, attributable to parent | (90) | (56) | (38) | (131) | (118) | (118) | |||
Common stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
Additional paid in capital | 76 | 76 | 76 | 23 | 23 | 23 | |||
Accumulated deficit | (165) | (131) | (114) | (154) | (141) | (140) | |||
Other undisclosed equity | (0) | ||||||||
Total equity: | (90) | (56) | (38) | (131) | (118) | (118) | |||
TOTAL LIABILITIES AND EQUITY: | 17 | 19 | 23 | 33 | 31 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
12/31/2024 Q1 | 9/30/2024 Q4 | 6/30/2024 Q3 | 3/31/2024 Q2 | 12/31/2023 Q1 | 9/30/2023 Q4 | 6/30/2023 Q3 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 2 | 8 | 4 | |||||
Gross profit: | 2 | 8 | 4 | |||||
Operating expenses | (16) | (16) | (14) | (15) | (8) | (8) | ||
Operating loss: | (16) | (16) | (14) | (13) | (0) | (4) | ||
Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (18) | (2) | 54 | |||||
Interest and debt expense | 55 | |||||||
Net income (loss): | (34) | (17) | 95 | (13) | (0) | (4) | ||
Other undisclosed net loss attributable to parent | (55) | |||||||
Net income (loss) available to common stockholders, diluted: | (34) | (17) | 40 | (13) | (0) | (4) |
Comprehensive Income ($ in thousands)Annual | Quarterly
12/31/2024 Q1 | 9/30/2024 Q4 | 6/30/2024 Q3 | 3/31/2024 Q2 | 12/31/2023 Q1 | 9/30/2023 Q4 | 6/30/2023 Q3 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (34) | (17) | 95 | (13) | (0) | (4) | ||
Comprehensive income (loss), net of tax, attributable to parent: | (34) | (17) | 95 | (13) | (0) | (4) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.